The human gene SRD5A2 encodes the 3-oxo-5α-steroid 4-dehydrogenase 2 enzyme, also known as 5α-reductase type 2 (5αR2), one of three isozymes of 5α-reductase.

5αR2 catalyzes the conversion of the male sex hormone testosterone into the more potent androgen, dihydrotestosterone.

5αR2 is a microsomal protein expressed at high levels in androgen-sensitive tissues such as the prostate. The enzyme is active at acidic pH and is sensitive to the 4-azasteroid inhibitor finasteride. Deficiencies in 5αR2 activity of the can lead to a condition known as 5α-reductase 2 deficiency, which is a cause of 46,XY DSD that presents as atypical male genitalia.

See also

  • 5α-Reductase

References

Further reading

This article incorporates text from the United States National Library of Medicine, which is in the public domain.



Overall structure of human SRD5A2 a 5αreduction reaction of the ∆4,5

Variants in the SRD5A2 gene are associated with quality of semen

Association between SRD5A2 protein level and pathological features in

SUSTech researchers reveal the mechanism of finasteridetargeted enzyme

Mouse SRD5a2(Steroid 5 Alpha Reductase 2) ELISA Kit